Fermenta Biotech Ltd. Investor Presentation

Fermenta Biotech Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter
All Jul-Sep 2025 Apr-Jun 2025 Jan-Mar 2025 Oct-Dec 2024 Jul-Sep 2024 Apr-Jun 2024 Jan-Mar 2024 Oct-Dec 2023 Jul-Sep 2023 Apr-Jun 2023 Jan-Mar 2023 Oct-Dec 2022 Jul-Sep 2022 Apr-Jun 2022 Jan-Mar 2022 Oct-Dec 2021 Jul-Sep 2021 Apr-Jun 2021 Jan-Mar 2021 Oct-Dec 2020 Jul-Sep 2020 Apr-Jun 2020 Jan-Mar 2020 Oct-Dec 2019 Jul-Sep 2019 Apr-Jun 2019 Jan-Mar 2019 Oct-Dec 2018 Jul-Sep 2018 Apr-Jun 2018 Jan-Mar 2018 Oct-Dec 2017 Jul-Sep 2017 Apr-Jun 2017 Jan-Mar 2017 Oct-Dec 2016 Jul-Sep 2016 Apr-Jun 2016 Jan-Mar 2016 Oct-Dec 2015
announcement
Conference/Earnings Calls Alerts
logo
Fermenta Biotech Ltd.
06 Dec 2019
362.00
-0.47%
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Intimation of Investor Relations Presentation Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for December 2019 for your information. The said Investor Presentation is also available on Company's website at www.dil.net Kindly take the same on records
pdf
logo
Fermenta Biotech Ltd.
18 Nov 2019
362.00
-0.47%
Fermenta Biotech Ltd - 506414 - Intimation Of Investor Presentation For November 2019
BSE India
Further to our intimation dated November 13, 2019 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2019, we hereby enclose a copy of Investor Presentation for November 2019. The said Investor Presentation is also available on Company's website www.dil.net
pdf
logo
Fermenta Biotech Ltd.
06 Nov 2019
362.00
-0.47%
pdf
logo
Fermenta Biotech Ltd.
06 Nov 2019
362.00
-0.47%
pdf
logo
Fermenta Biotech Ltd.
08 Aug 2019
362.00
-0.47%
DIL LTD. - 506414 - Intimation Of Investor Presentation For August 2019
BSE India
Further to our intimation dated August 5, 2019 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter ended June 30, 2019, we hereby enclose a copy of Investor Presentation for August 2019. The said Investor Presentation is also available on Company's website www.dil.net
pdf
logo
Fermenta Biotech Ltd.
30 May 2019
362.00
-0.47%
Dil Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Further to our intimation dated May 24, 2019 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended March 31, 2019, we hereby enclose a copy of Investor Presentation for May 2019. The said Investor Presentation is also available on Company's website www.dil.net
pdf
logo
Fermenta Biotech Ltd.
13 Feb 2019, 12:42PM
362.00
-0.47%
Dil Ltd - 506414 - Intimation Of Investor Presentation For February 2019
BSE India
Further to our intimation dated February 12, 2019 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2018, we hereby enclose a copy of Investor Presentation for February 2019. The said Investor Presentation is also available on Company's website www.dil.net
pdf
logo
Fermenta Biotech Ltd.
15 Nov 2018
362.00
-0.47%
Intimation Of Investor Presentation For November 2018
BSE India
Further to our intimation dated November 13, 2018 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2018, we hereby enclose a copy of Investor Presentation for November 2018. The said Investor Presentation is also available on Company's website www.dil.net
pdf
logo
Fermenta Biotech Ltd.
13 Nov 2018, 04:13PM
362.00
-0.47%
Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Intimation of Investor Release for November 2018 Further to our intimation dated November 13, 2018 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and half year ended September 30, 2018, we hereby enclose a copy of Investor Release for November 2018. The said Investor Release is also available on Company's website www.dil.net
pdf
logo
Fermenta Biotech Ltd.
16 Aug 2018
362.00
-0.47%
Intimation Of Investor Presentation For August 2018
BSE India
Further to our intimation dated August 14, 2018 regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter ended June 30, 2018, we hereby enclose a copy of Investor Presentation for August 2018. The said Investor Presentation is also available on Company's website www.dil.net
pdf